MDX‐1097 induces antibody‐dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|169|3|333-343

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.169, Iss.3, 2015-05, pp. : 333-343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic variation of human neutrophil Fcγ receptors and SIRPα in antibody‐dependent cellular cytotoxicity towards cancer cells

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 48, Iss. 2, 2018-02 ,pp. : 344-354

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Partially Inhibits the Trastuzumab-Mediated Antibody-Dependent Cellular Cytotoxicity of Human Monocytes

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 172-180

Karger

Access to resources Recommend Favorite

Pharmacoeconomic Implications of Lenalidomide Maintenance Therapy in Multiple Myeloma

By  

Oncology, Vol. 87, Iss. 4, 2014-07 ,pp. : 224-231

Karger

Access to resources Recommend Favorite

An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger Complement-Dependent Cytotoxicity and Antibody-Dependent Cell-Mediated Cytotoxicity

By  

Transfusion Medicine and Hemotherapy, Vol. 44, Iss. 5, 2017-09 ,pp. : 292-300

Karger

Access to resources Recommend Favorite

Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myeloma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 174, Iss. 6, 2016-09 ,pp. : 911-922

John Wiley & Sons Inc

Access to resources Recommend Favorite